Stocks rise over Pfizer’s Covid vaccine

THE rally in global equities extended Tuesday, a day after Pfizer said its late-stage trial of its Covid-19 vaccine had shown promising results, but caution over the depth of the coronavirus pandemic and an uncertain US political climate limited gain. Futures tied to the Dow Jones Industrial Average, the S&P 500, and the Nasdaq rose…

Subscribe to read full article. Subscribe today

Related posts

Dangote appoints MTN CEO to fertiliser unit board with IPO plans

Zambia restates copper ambition after posting record output

Netflix boosts bridge loan for Warner Bros deal to $42 billion

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More